Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension

New England Journal of Medicine

Volumn 340, Issue 9, 1999, Pages 677-684

  Tuomilehto, Jaakko ^a   Rastenyte, Daiva ^b   Birkenhager, Willem H ^c   Thijs, Lutgarde ^d   Antikainen, Riitta ^e   Bulpitt, Christopher J ^f   Fletcher, Astrid E ^g   Forette, Françoise ^h   Goldhaber, Adiv ^j   Palatini, Paolo ⁱ   Sarti, Cinzia ^a   Fagard, Robert ^d   Staessen, Jan A ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h Paris Descartes University   (France)

ⁱ Istituto di Medicina Clinica Padova   (Italy)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NITRENDIPINE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG USE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; NITRENDIPINE; PROPORTIONAL HAZARDS MODELS; SYSTOLE;

EID: 0033522149     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199903043400902     Document Type: Article

References (30)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
2. Epstein M. Calcium antagonists and renal protection: current status and future perspectives. Arch Intern Med 1992;152:1573-84.
3. Giugliano D, De Rosa N, Marfella R, et al. Comparison of nitrendipine and cilazapril in patients with hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 1993;6:927-32.
4. Furberg CD, Psaty BM, Meyer JV. Nifedipinc: dose related increase in mortality in patients with coronary heart disease. Circulation 1995;92: 1326-31.
5. Tatti P, Pahor M, Byington RB, et al. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603.
6. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645-52.
7. Alderman M, Madhavan S, Cohen H. Calcium antagonists and cardiovascular events in patients with hypertension and diabetes. Lancet 1998; 351:216-7.
8. Byington RP, Craven TE, Furberg CD, Pahor M. Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events. Lancet 1998; 350:1075-6.
9. Pahor M, Kritchevsky SB, Zuccala G, Guralnik JM. Diabetes and risk of adverse events with calcium antagonists. Diabetes Care 1998;21:193-4.
10. Pahor M, Psaty BM, Furberg CD. Treatment of hypertensive patients with diabetes. Lancet 1998;351:689-90.
11. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64. [Erratum, Lancet 1997;350: 1636.]
12. Staessen JA, Fagard R, Thijs L, et al. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med 1998;158:1681-91.
13. Amery A, Birkenhäger W, Bulpitt CJ, et al. Syst-Eur: a multkentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) 1991;3:287-302.
14. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990;24:606-9.
15. Prevention of diabetes mellitus: report of a WHO study group. World Health Organ 1994;844:1-100.
16. Staessen JA, Thijs L, Bijttebier G, et al. Determining the trough-to-peak ratio in parallel-group trials. Hypertension 1997;29:659-67.
17. Staessen JA, Thijs L, Fagard RH, et al. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension. Hypertension 1998;32:410-6.
18. Lever AF, Ramsay LE. Treatment of hypertension in the elderly. J Hypertens 1995;13:571-9.
19. The SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
20. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-92. [Erratum, JAMA 1997;277:1356.]
21. Sowers JR. Effects of calcium antagonists on insulin sensitivity and other metabolic parameters. Am J Cardiol 1997;79:24-8.
22. Ricciardelli B, Argcnziano L, Morisco C, Monti F, Barbato E, Trimarco B. Effects of nitrendipine on plasma levels of insulin and glucose in patients with essential hypertension. Curr Ther Res 1997;58:180-6.
23. Amery A, Birkenhäger W, Bulpitt C, et al. Diuretics - a risk in the long term treatment of hypertensive patients? J Hypertens 1988;6:125-30.
24. Goa KL, Sorkin EM. Nitrendipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs 1987;33:123-55.
25. Taddei S, Virdis A, Ghiadoni L, Ulcri S, Magagna A, Salvetti A. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension 1997;30:1606-12.
26. Berkeis R, Bertsch A, Breitenbach T, Klaus W, Roesen R. The calcium modulator nifedipine stimulates endothelial NO release in therapeutical concentrations. Pharm Pharmacol Lett 1996;6:75-8.
27. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium channel blockade and incidence of cancer in aged populations. Lancet 1996;648:493-7
28. Alderman MH, Cohen H, Roqué R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997;349:594-8.
29. Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipinc Diuretic Atherosclerosis Study (MIDAS): a randomized controlled trial. JAMA 1996;276:785-91.
30. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.